Monoallelic TP53 abnormalities in CLL: do they really exist? The frequency and clinical impact of copy-neutral loss of heterozygosity

PLEVOVÁ, Karla, Jitka MALČÍKOVÁ, Jana ŠMARDOVÁ, Eva DIVÍŠKOVÁ, Jana KOTAŠKOVÁ, Martin TRBUŠEK, Yvona BRYCHTOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ. Monoallelic TP53 abnormalities in CLL: do they really exist? The frequency and clinical impact of copy-neutral loss of heterozygosity. In 2nd Interantional Conference on New Concepts in B-cell malignancies. 2016.

Basic information

• Original name: Monoallelic TP53 abnormalities in CLL: do they really exist? The frequency and clinical impact of copy-neutral loss of heterozygosity
• Authors: PLEVOVÁ, Karla, Jitka MALČÍKOVÁ, Jana ŠMARDOVÁ, Eva DIVÍŠKOVÁ, Jana KOTAŠKOVÁ, Martin TRBUŠEK, Yvona BRYCHTOVÁ, Michael DOUBEK and Šárka POSPÍŠILOVÁ.
• Edition: 2nd Interantional Conference on New Concepts in B-cell malignancies, 2016.

Other information

• Type of outcome: Conference abstract
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Central European Institute of Technology

Links

• LQ1601, research and development project: Name: CEITEC 2020 (Acronym: CEITEC2020)

Investor: Ministry of Education, Youth and Sports of the CR

• 15-31834A, interní kód MU(CEP code: NV15-31834A): Name: Vliv selekce genomických poškození na průběh chronické lymfocytární leukémie

Investor: Ministry of Health of the CR

• 692298, interní kód MU: Name: MEDGENET - Medical genomics and epigenomics network (Acronym: MEDGENET)

Investor: European Union, Spreading excellence and widening participation